Testagen

Overview

What is Testagen?

Testagen (KEDG, Lys-Glu-Asp-Gly) is a synthetic tetrapeptide bioregulator developed by Russian scientist Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology. Derived from amino acid sequences found in anterior pituitary gland extracts, Testagen is researched for its potential effects on thyroid-stimulating hormone (TSH) release, thyroid function, and downstream testosterone regulation. As part of the Khavinson peptide family, it is proposed to cross cell and nuclear membranes to directly interact with DNA and modulate gene expression in target tissues.

Key Benefits

Direct systemic absorption, precise dosing control, bypasses GI degradation, supports anterior pituitary function, potential thyroid and testosterone optimization through TSH modulation.

Mechanism of Action

Testagen (KEDG) is proposed to cross both cell and nuclear membranes to interact directly with DNA in anterior pituitary cells. This may stimulate TSH release, subsequently influencing T3/T4 thyroid hormone production. Improved thyroid function is correlated with normalized testosterone levels, suggesting a potential indirect mechanism for testosterone support.

Pharmacokinetics

Peak: 15 min Half-life: 30 min Cleared: ~2.5 hrs

Research Indications

Endocrine Most Effective

Anterior Pituitary Support

Research suggests Testagen may stimulate anterior pituitary function, potentially enhancing release of thyroid-stimulating hormone (TSH) and supporting overall endocrine regulation.

Thyroid Function Optimization

Studies indicate Testagen may increase TSH release, subsequently influencing T3 and T4 thyroid hormone production, even without full hypophyseal support.

Testosterone Support (Indirect)

Research correlates hypothyroidism with reduced testosterone. By potentially optimizing thyroid function, Testagen may indirectly support testosterone levels.

Aging Effective

Age-Related Hormone Decline

Part of Khavinson’s bioregulator family studied for geroprotective effects. May help address age-related decline in pituitary-thyroid-gonadal axis function.

Cellular Gene Expression

Short peptides like Testagen are proposed to epigenetically regulate gene expression by interacting with DNA and histones in target tissues.

Bioregulator Therapy

Used in Russian clinical practice as part of comprehensive peptide bioregulator protocols for age-related endocrine optimization.

Metabolic Most Effective

Metabolic Rate Support

Through potential thyroid hormone modulation, Testagen may indirectly support basal metabolic rate and energy metabolism.

Body Composition

Optimal thyroid and testosterone levels are associated with improved body composition. Testagen’s endocrine effects may support these outcomes.

Energy and Vitality

Thyroid hormone optimization is associated with improved energy levels, stamina, and overall vitality.

Research Protocols

Disclaimer

These are commonly discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified healthcare provider.

Goal	Dose	Frequency	Route
Starting / Titration (Weeks 1-2)	100mcg	Once daily	SubQ
Building (Weeks 3-4)	150mcg	Once daily	SubQ
Standard (Weeks 5-8)	200mcg	Once daily	SubQ
Maximum (Weeks 9-12)	250-300mcg	Once daily	SubQ

Timing

Administer SubQ once daily, preferably in the morning to align with natural circadian hormone rhythms. TSH and thyroid hormone release follow diurnal patterns. Consistent daily timing helps maintain stable peptide levels.

Peptide Interactions

Epitalon Synergistic

Both are Khavinson bioregulators - Epitalon targets pineal function while Testagen targets anterior pituitary. Commonly used together in Russian anti-aging protocols.

Pinealon Synergistic

Complementary bioregulators - Pinealon supports pineal/brain function while Testagen supports pituitary-gonadal axis.

Thymalin Compatible

Both are Khavinson bioregulators with different targets (thymus vs pituitary). No known negative interactions.

CJC-1295 Monitor Combination

Both affect pituitary function - CJC-1295 stimulates GH release while Testagen may affect TSH. Monitor for hormonal changes.

Ipamorelin Compatible

Different pituitary targets - Ipamorelin stimulates GH via ghrelin receptor, Testagen targets TSH pathways.

BPC-157 Compatible

No direct interaction - work through completely different mechanisms (tissue repair vs endocrine regulation).

Thyroid Medications Monitor Combination

Testagen may affect TSH and thyroid hormone levels - monitor thyroid function closely if on thyroid medications.

TRT/Testosterone Monitor Combination

Both affect testosterone levels through different mechanisms. Monitor hormone levels if combining.

How to Reconstitute

Important

Always use bacteriostatic water (BAC). Sterile technique is essential.

1
Add 3.0mL BAC water to 20mg vial = 6.67mg/mL (6670mcg/mL)
2
At this concentration: 1 unit = ~67mcg on U-100 syringe
3
Inject BAC water slowly down vial wall, avoid direct contact with powder
4
Gently swirl or roll until dissolved - do NOT shake
5
Allow to sit 2-3 minutes if any cloudiness, swirl again until clear
6
For 100mcg dose: draw 1.5 units; for 200mcg: 3 units; for 300mcg: 4.5 units
7
Store reconstituted solution refrigerated at 2-8°C

Quality Indicators

✓

White Lyophilized Powder

Properly freeze-dried Testagen appears as white, fluffy powder cake without clumping or discoloration.
✓

Clear Reconstituted Solution

When mixed with BAC water, solution should be completely clear and colorless with no particles.
✓

Verified Source with COA

Obtain from reputable peptide suppliers with Certificate of Analysis showing purity >98%.
!

Limited Research Base

Testagen has limited Western clinical data. Most research originates from Russian bioregulator programs.
X

Discoloration or Particles

Any yellow/brown coloration or visible particles indicates degradation - do not use.
X

Unknown Source

Never use peptides from unverified sources without third-party testing confirmation.

What to Expect

Weeks 1-2: Establishing baseline, minimal noticeable effects
Weeks 3-4: Potential subtle improvements in energy and mood
Weeks 5-8: Possible thyroid function optimization, improved metabolic rate
Weeks 8-12: Full effects on thyroid-testosterone axis may manifest
Effects are subtle and cumulative - this is a bioregulator, not a hormone
Consider hormone panel testing before and after cycle for objective assessment

Side Effects & Safety

No human clinical trials exist - all guidance from preclinical research
Contraindicated in individuals with thyroid cancer or hyperthyroidism
Monitor thyroid function if on thyroid medications
Start with lower dose to assess individual response
Rotate injection sites systematically to prevent tissue damage
Use fine gauge needle (23-31G) for comfort
Not recommended during pregnancy or breastfeeding
Consult healthcare provider before use, especially with existing endocrine conditions

Signs of hyperthyroidism (rapid heartbeat, tremor, heat intolerance, weight loss)
Significant mood changes or anxiety
Neck swelling or thyroid enlargement
Severe injection site reactions
Allergic reaction (rash, swelling, difficulty breathing)
Any concerning or unexpected symptoms

References

Hypophysectomized Avian Model Study

Avian model | Pituitary-removed birds | Thyroid gland morphology assessment

In hypophysectomized avian models, introduction of the KEDG peptide was associated with changes in thyroid gland morphology, body weight, and follicle structure. Apparent shifts were noted in thyroid-related hormones, suggesting possible interactions with pituitary-thyroid regulation even without hypophyseal support.

Thyroid Function Without Hypophyseal Support

Preclinical | TSH and thyroid hormone modulation | Gene expression analysis

Research suggests Testagen stimulates the anterior pituitary gland to increase release of thyroid stimulating hormone (TSH) and subsequently T3 and T4 thyroid hormones. Notably, this effect was observed even without hypophyseal support, suggesting direct alteration of protein expression patterns in pituitary tissue.

Peptide Bioregulator Thyroid Correction Study (2005)

Humans | Magadan Region | Elderly with hypothyroidism | Thyramin bioregulator

Clinical study of peptide bioregulators for thyroid correction in elderly residents. Thyramin (related pituitary bioregulator) demonstrated tissue-specific effects on thyroid cells and restoration of disturbed thyroid tissue function in patients with age-related hypothyroidism.

View Study →

Khavinson Peptide Gene Expression Study

In vitro | Short peptides | DNA and histone interaction analysis

Research by Khavinson demonstrated that short peptides like Testagen can penetrate both cell and nuclear membranes to interact directly with DNA and histones. This epigenetic interaction may influence gene expression and protein synthesis pathways in target tissues.

Testosterone and Thyroid Hormone Correlation

Research review | Hypothyroidism and testosterone relationship

Research correlates hypothyroidism with diminished testosterone levels. Thyroid hormone normalization through replacement therapy restored free testosterone concentrations, suggesting Testagen's testosterone effects may be mediated through thyroid hormone modulation.